Home » Market News » DirectorsTalk Highlights » A focus on the rise of cannabidiol (CBD)
Sativa Group

A focus on the rise of cannabidiol (CBD)

George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD)

Rewind two or three years and CBD wasn’t even on the radar of the fast-moving consumer goods (FMCG) sector; now it’s a £300 million industry, bigger than the total UK Vitamin D and Vitamin C markets combined. To date, over 6 million adults have put CBD to the test and the industry shows no signs of slowing down.

Sativa Group Plc (NEX:SATI) is the UK’s leading quoted CBD Wellness and medicinal cannabis group with five operating subsidiaries. Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD Wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfill its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.